$3.20
▲ +0.3% Today
as of Jul 22, 16:45 ET
Last 30 days
Recent Press Releases & News
Alvotech Faces 'Soft' Q2 but Well Positioned to Benefit From Upcoming Biosimilar Opportunity, UBS Says
Alvotech (ALVO) Stock May Be Undervalued Following Its $125 Million Offering
Alvotech’s US$240 Million Capital Boost Might Change The Case For Investing In Alvotech (ALVO)
Overview
52-week range
$2.94
$11
3% of range
Avg surprise (last 3)
+143.7%
Avg reaction (last 2)
+0.8%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 6, 2026 | Mar/2026 | $-0.09 | $-0.07 | -28.6% | -125.7% | +2.0% | earnings |
| Wed Aug 13, 2025 | Jun/2025 | $0.14 | $-0.26 | +153.8% | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $0.35 | $-0.17 | +305.9% | — | -0.4% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 12, 2026 | Jun/2026 | OTHER | -$0.05 | $0.14 | -135.7% |
Implied volatility — last 90 days
No IV snapshots yet for ALVO.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.